Clinical trials
Dysplasia clinical trials
Below are recruiting dysplasia clinical trials, each written for real people, not researchers. We’re tracking 160 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07210775RecruitingPhase 1/Phase 2
Imiquimod cream for mouth precancer
This trial tests a cream called imiquimod for people who have been diagnosed with oral dysplasia, a precancerous condition in the mouth. It is an option for those who cannot or choose not to have surgery or laser treatment.
Los Angeles, CaliforniaAges 18 years+ - NCT04980638RecruitingPhase 2
Check ER004 given in the womb for a genetic tooth-skin disorder
This Phase 2 study tests ER004 put into the amniotic fluid during pregnancy to treat male babies with X-linked hypohidrotic ectodermal dysplasia (XLHED). It also looks at effects in affected male relatives with the same gene change.
Los Angeles, CaliforniaAges 18 years+ - NCT06342752Recruiting
Breath test for early lung disease in premature babies
This trial studies a breath test to predict lung disease in very premature babies. It could help doctors start treatment earlier to prevent serious breathing problems.
Edegem, AntwerpAges birth–3 days - NCT07120971RecruitingEarly Phase 1
Metformin study for premature babies with lung disease
This study tests whether metformin, a medicine used for diabetes, can help premature babies with chronic lung disease (bronchopulmonary dysplasia, or BPD) breathe better. It may reduce the need for breathing machines.
Milwaukee, WisconsinAges 1 week–6 months - NCT07111858Recruiting
Pavlik harness vs monitoring for hip dysplasia in babies
This trial compares using a soft brace (Pavlik harness) versus simply monitoring for babies diagnosed with a certain type of hip condition (Graf type 2b or 2c). Researchers want to see which approach leads to better hip development and avoids the need for more intensive treatment.
Royal Tunbridge WellsAges birth–4 months - NCT07101640RecruitingPhase 1/Phase 2
Montelukast study for breathing problems in premature infants
This trial tests if the medicine montelukast can help very premature babies on breathing machines. It aims to see if it improves lung development and makes it easier for them to breathe on their own.
Little Rock, ArkansasAges 1 week–4 weeks - NCT07066852Enrolling by invitation
Hip screening for Turkish newborns at risk
This trial checks how well a hip screening program works for Turkish babies born in a specific hospital. It aims to find developmental hip problems early so they can be treated.
Ankara, AnkaraAges Any age - NCT05225311Recruiting
Registry for pregnancies with Ebstein and tricuspid valve issues
This registry collects information about pregnancies where the baby is diagnosed with Ebstein anomaly and/or tricuspid valve dysplasia. It helps doctors learn how these heart conditions affect pregnancies and outcomes, and can support better future care.
Toronto, OntarioAges Any age - NCT06954142Recruiting
Fluid levels to prevent lung disease in preterm babies
This trial compares giving less fluid versus the usual amount to very early preterm babies to see if it helps prevent bronchopulmonary dysplasia, a chronic lung condition. The goal is to find the safest way to manage fluids and protect their developing lungs.
AarauAges 1 week+ - NCT06925360RecruitingPhase 2
IVIG for lung disease in premature babies
This trial tests if intravenous immunoglobulin (IVIG) can help prevent or treat bronchopulmonary dysplasia (BPD), a lung condition in premature babies. It is for very preterm infants born between 25 and 29 weeks who show early signs of BPD and are enrolled in the first day of life.
Shanghai, Shanghai MunicipalityAges Up to 2 months - NCT06897839RecruitingPhase 2/Phase 3
Testing zelpultide alfa for preterm babies at risk of lung disease
This trial tests a medicine called zelpultide alfa in very premature babies who are at high risk of developing bronchopulmonary dysplasia (BPD), a chronic lung disease. The goal is to see if it can help prevent or lessen lung problems compared to standard care alone.
Buenos AiresAges birth–4 days - NCT03231644Recruiting
Registry for fibrous dysplasia and related conditions
This is a patient registry that collects health information from people with fibrous dysplasia, McCune-Albright syndrome, or Mazabraud’s syndrome. It helps researchers understand these conditions better and may support future studies.
Bethesda, MarylandAges Any age - NCT06647225Recruiting
AI screening for hip dysplasia in babies
This trial tests whether an artificial intelligence tool can help doctors more accurately diagnose hip dysplasia in babies using ultrasound images. It might help your baby get a faster and more precise diagnosis if they are already being checked for a hip problem.
Parkville, VictoriaAges 4 weeks–5 months - NCT06534359Recruiting
Gastric vs transpyloric feeding for BPD
This study compares two ways of feeding premature babies with lung disease (BPD) who still need breathing support: feeding through a tube into the stomach (gastric) versus past the stomach into the small intestine (transpyloric). The goal is to see which feeding method helps these babies grow better and avoid problems.
Palo Alto, CaliforniaAges 1 month–1 year - NCT06475976Recruiting
Identifying lung types in severe BPD in preemies
This study looks at babies born very early who have severe lung disease (grade 3 BPD) and still need a breathing machine. Researchers will use tests to understand their lung problems better, which may help guide their care.
Philadelphia, PennsylvaniaAges 1 month–1 year - NCT04098744RecruitingPhase 2
Artesunate vaginal inserts for high-grade cervical changes
This Phase 2 study tests whether artesunate vaginal inserts can help treat high-grade abnormal cells on the cervix (CIN2/3). It’s meant for adults who have a confirmed high-grade precancer change and can use birth control during the study.
Fort Myers, FloridaAges 25–100 - NCT06071845Recruiting
Testing a simpler sponge test for Barrett's esophagus
This study tests a new, less invasive way to collect cells from the esophagus using a small sponge on a string (called Cytosponge). It aims to see if this method can accurately detect Barrett's esophagus, a condition that can raise the risk of esophageal cancer.
Scottsdale, ArizonaAges 18–90 - NCT05965999Recruiting
Registry study for esophageal precancer screening
This study collects information from people who are already being screened for Barrett's esophagus or esophageal cancer using the EsoCheck and EsoGuard tests. It helps doctors learn more about how well these tests work in real life.
Lake Forest, CaliforniaAges Any age - NCT05753748Recruiting
Surveillance vs. endoscopic treatment for Barrett's esophagus with low-grade dysplasia
This study compares two approaches for people with Barrett's esophagus and low-grade dysplasia: regular surveillance (monitoring with endoscopies) versus endoscopic treatment to remove the abnormal cells. It aims to see which approach is better at preventing progression to more serious conditions.
Birmingham, AlabamaAges 18–89 - NCT05745857RecruitingPhase 2
Scan for early esophagus cancer using infused antibody dyes
This Phase 2 study uses special drug dyes (bevacizumab and cetuximab, each tagged for imaging) during an esophagus scope to help doctors find very early abnormal cells, like low- or high-grade pre-cancer and superficial cancer. If you qualify, the goal is earlier detection and better targeting during diagnosis and treatment.
Groningen, Provincie GroningenAges 18 years+ - NCT04795843Recruiting
Exercise and education versus usual care for hip dysplasia
This trial compares a structured exercise and patient education program with standard care in people with hip dysplasia. It may help improve hip and groin pain and function, especially if you are not getting the usual surgery (periacetabular osteotomy, or PAO).
Aarhus NAges 18–50 - NCT04561791Enrolling by invitation
Testing a swallowable scope for early detection of Barrett’s esophagus
This study checks whether a special swallowable “camera capsule” test done in primary care can find early warning changes called Barrett’s esophagus. If it works well, it could make screening easier for people at risk.
Boston, MassachusettsAges 18–75 - NCT04270045Recruiting
Breathing test in babies with bronchopulmonary dysplasia
This trial studies a breathing measurement test (forced oscillometry) in babies who were born early and have bronchopulmonary dysplasia (BPD), a long-term lung condition. It may help doctors better understand how babies’ lungs are working and guide future care.
Kansas City, MissouriAges Any age - NCT01967511Recruiting
Study to better understand fibromuscular dysplasia
This trial studies people with fibromuscular dysplasia (FMD) and related conditions to learn what causes them and how they behave over time. You may also be able to join if you are a healthy person matched by age and gender to help compare results.
New York, New YorkAges 18 years+
Hear when a new Dysplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for dysplasia?
- Yes. Clin2 currently lists 160 recruiting dysplasia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a dysplasia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a dysplasia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.